Comparing Renal Biomarkers and Utility to Monitor Immunosuppression

Shahid Muhammad

Editorial: LAP Lambert Academic Publishing Feb 2016, 2016
ISBN 10: 3659835714 / ISBN 13: 9783659835711
Usado / Taschenbuch / Cantidad: 0
Disponible en otras librerías
Ver todos  los ejemplares de este libro

Sobre el libro

Lamentablemente este ejemplar en específico ya no está disponible. A continuación, le mostramos una lista de copias similares.

Descripción:

Neuware - Chronic Kidney Disease (CKD) is on the rise in all ethnicities. Evidence also highlights that this disease negatively impacts quality of life and places an enormous financial implications on the health care system for the provision of care to patients. Thus, it is of utmost importance to devise strategies that prevent CKD and delay progressive loss of renal function in the wider population. Biomedical scientists now have a more active and larger role to play with respect to monitoring. Whilst there have been guidelines on the screening and monitoring of anticoagulation-based medication, there perhaps needs to be more collaborative guidelines to monitor mainstay IST post-transplant patients receive. Specialists from both clinical and laboratory practice need to come together to further inform which biomarkers would be specific for monitoring IST titres. Individuals who are at high risk of CKD need better 'preparation' and prompt early referral to secondary care is a must in order to allow the best prognosis. In addition, the utility of biomarkers for monitoring post-transplant immunosuppression has to become more specific for patients post-transplant. 60 pp. Englisch. N° de ref. de la librería

Sobre este título:

Sinopsis: Chronic Kidney Disease (CKD) is on the rise in all ethnicities. Evidence also highlights that this disease negatively impacts quality of life and places an enormous financial implications on the health care system for the provision of care to patients. Thus, it is of utmost importance to devise strategies that prevent CKD and delay progressive loss of renal function in the wider population. Biomedical scientists now have a more active and larger role to play with respect to monitoring. Whilst there have been guidelines on the screening and monitoring of anticoagulation-based medication, there perhaps needs to be more collaborative guidelines to monitor mainstay IST post-transplant patients receive. Specialists from both clinical and laboratory practice need to come together to further inform which biomarkers would be specific for monitoring IST titres. Individuals who are at high risk of CKD need better ‘preparation’ and prompt early referral to secondary care is a must in order to allow the best prognosis. In addition, the utility of biomarkers for monitoring post-transplant immunosuppression has to become more specific for patients post-transplant.

About the Author: Shahid is a Specialist Biomedical Scientist, a member of the Institute of Biomedical Sciences (MIBMS), a member of the British Blood and Transfusion Society (BBTS), a registered Scientist under the Science Council (RSci) and a member of the Healthcare Professionals Council (HCPC). Shahid writes to join efforts in care of patients in CKD.

"Sobre este título" puede pertenecer a otra edición de este libro.

Detalles bibliográficos

Título: Comparing Renal Biomarkers and Utility to ...
Editorial: LAP Lambert Academic Publishing Feb 2016
Año de publicación: 2016
Encuadernación: Taschenbuch
Condición del libro: Neu

Los mejores resultados en AbeBooks

1.

Muhammad, Shahid
ISBN 10: 3659835714 ISBN 13: 9783659835711
Nuevos Cantidad: 1
Librería
Valoración
[?]

Descripción Estado de conservación: New. Publisher/Verlag: LAP Lambert Academic Publishing | Chronic Kidney Disease (CKD) is on the rise in all ethnicities. Evidence also highlights that this disease negatively impacts quality of life and places an enormous financial implications on the health care system for the provision of care to patients. Thus, it is of utmost importance to devise strategies that prevent CKD and delay progressive loss of renal function in the wider population. Biomedical scientists now have a more active and larger role to play with respect to monitoring. Whilst there have been guidelines on the screening and monitoring of anticoagulation-based medication, there perhaps needs to be more collaborative guidelines to monitor mainstay IST post-transplant patients receive. Specialists from both clinical and laboratory practice need to come together to further inform which biomarkers would be specific for monitoring IST titres. Individuals who are at high risk of CKD need better 'preparation' and prompt early referral to secondary care is a must in order to allow the best prognosis. In addition, the utility of biomarkers for monitoring post-transplant immunosuppression has to become more specific for patients post-transplant. | Format: Paperback | Language/Sprache: english | 60 pp. Nº de ref. de la librería K9783659835711

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 35,65
Convertir moneda

Añadir al carrito

Gastos de envío: EUR 2,99
De Alemania a Estados Unidos de America
Destinos, gastos y plazos de envío

2.

Shahid Muhammad
Editorial: LAP Lambert Academic Publishing Feb 2016 (2016)
ISBN 10: 3659835714 ISBN 13: 9783659835711
Nuevos Taschenbuch Cantidad: 1
Librería
Agrios-Buch
(Bergisch Gladbach, Alemania)
Valoración
[?]

Descripción LAP Lambert Academic Publishing Feb 2016, 2016. Taschenbuch. Estado de conservación: Neu. Neuware - Chronic Kidney Disease (CKD) is on the rise in all ethnicities. Evidence also highlights that this disease negatively impacts quality of life and places an enormous financial implications on the health care system for the provision of care to patients. Thus, it is of utmost importance to devise strategies that prevent CKD and delay progressive loss of renal function in the wider population. Biomedical scientists now have a more active and larger role to play with respect to monitoring. Whilst there have been guidelines on the screening and monitoring of anticoagulation-based medication, there perhaps needs to be more collaborative guidelines to monitor mainstay IST post-transplant patients receive. Specialists from both clinical and laboratory practice need to come together to further inform which biomarkers would be specific for monitoring IST titres. Individuals who are at high risk of CKD need better 'preparation' and prompt early referral to secondary care is a must in order to allow the best prognosis. In addition, the utility of biomarkers for monitoring post-transplant immunosuppression has to become more specific for patients post-transplant. 60 pp. Englisch. Nº de ref. de la librería 9783659835711

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 35,90
Convertir moneda

Añadir al carrito

Gastos de envío: EUR 17,13
De Alemania a Estados Unidos de America
Destinos, gastos y plazos de envío

3.

Shahid Muhammad
Editorial: LAP Lambert Academic Publishing Feb 2016 (2016)
ISBN 10: 3659835714 ISBN 13: 9783659835711
Nuevos Taschenbuch Cantidad: 1
Librería
Rheinberg-Buch
(Bergisch Gladbach, Alemania)
Valoración
[?]

Descripción LAP Lambert Academic Publishing Feb 2016, 2016. Taschenbuch. Estado de conservación: Neu. Neuware - Chronic Kidney Disease (CKD) is on the rise in all ethnicities. Evidence also highlights that this disease negatively impacts quality of life and places an enormous financial implications on the health care system for the provision of care to patients. Thus, it is of utmost importance to devise strategies that prevent CKD and delay progressive loss of renal function in the wider population. Biomedical scientists now have a more active and larger role to play with respect to monitoring. Whilst there have been guidelines on the screening and monitoring of anticoagulation-based medication, there perhaps needs to be more collaborative guidelines to monitor mainstay IST post-transplant patients receive. Specialists from both clinical and laboratory practice need to come together to further inform which biomarkers would be specific for monitoring IST titres. Individuals who are at high risk of CKD need better 'preparation' and prompt early referral to secondary care is a must in order to allow the best prognosis. In addition, the utility of biomarkers for monitoring post-transplant immunosuppression has to become more specific for patients post-transplant. 60 pp. Englisch. Nº de ref. de la librería 9783659835711

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 35,90
Convertir moneda

Añadir al carrito

Gastos de envío: EUR 17,13
De Alemania a Estados Unidos de America
Destinos, gastos y plazos de envío

4.

Shahid Muhammad
Editorial: LAP Lambert Academic Publishing Feb 2016 (2016)
ISBN 10: 3659835714 ISBN 13: 9783659835711
Nuevos Taschenbuch Cantidad: 1
Impresión bajo demanda
Librería
AHA-BUCH GmbH
(Einbeck, Alemania)
Valoración
[?]

Descripción LAP Lambert Academic Publishing Feb 2016, 2016. Taschenbuch. Estado de conservación: Neu. This item is printed on demand - Print on Demand Neuware - Chronic Kidney Disease (CKD) is on the rise in all ethnicities. Evidence also highlights that this disease negatively impacts quality of life and places an enormous financial implications on the health care system for the provision of care to patients. Thus, it is of utmost importance to devise strategies that prevent CKD and delay progressive loss of renal function in the wider population. Biomedical scientists now have a more active and larger role to play with respect to monitoring. Whilst there have been guidelines on the screening and monitoring of anticoagulation-based medication, there perhaps needs to be more collaborative guidelines to monitor mainstay IST post-transplant patients receive. Specialists from both clinical and laboratory practice need to come together to further inform which biomarkers would be specific for monitoring IST titres. Individuals who are at high risk of CKD need better 'preparation' and prompt early referral to secondary care is a must in order to allow the best prognosis. In addition, the utility of biomarkers for monitoring post-transplant immunosuppression has to become more specific for patients post-transplant. 60 pp. Englisch. Nº de ref. de la librería 9783659835711

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 35,90
Convertir moneda

Añadir al carrito

Gastos de envío: EUR 29,50
De Alemania a Estados Unidos de America
Destinos, gastos y plazos de envío

5.

Shahid Muhammad
Editorial: LAP Lambert Academic Publishing (2016)
ISBN 10: 3659835714 ISBN 13: 9783659835711
Nuevos Paperback Cantidad: 1
Librería
The Book Depository EURO
(London, Reino Unido)
Valoración
[?]

Descripción LAP Lambert Academic Publishing, 2016. Paperback. Estado de conservación: New. Language: English . Brand New Book. Chronic Kidney Disease (CKD) is on the rise in all ethnicities. Evidence also highlights that this disease negatively impacts quality of life and places an enormous financial implications on the health care system for the provision of care to patients. Thus, it is of utmost importance to devise strategies that prevent CKD and delay progressive loss of renal function in the wider population. Biomedical scientists now have a more active and larger role to play with respect to monitoring. Whilst there have been guidelines on the screening and monitoring of anticoagulation-based medication, there perhaps needs to be more collaborative guidelines to monitor mainstay IST post-transplant patients receive. Specialists from both clinical and laboratory practice need to come together to further inform which biomarkers would be specific for monitoring IST titres. Individuals who are at high risk of CKD need better ?preparation? and prompt early referral to secondary care is a must in order to allow the best prognosis. In addition, the utility of biomarkers for monitoring post-transplant immunosuppression has to become more specific for patients post-transplant. Nº de ref. de la librería KNV9783659835711

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 53,85
Convertir moneda

Añadir al carrito

Gastos de envío: EUR 3,39
De Reino Unido a Estados Unidos de America
Destinos, gastos y plazos de envío